Skip to market wire
← Back to Stock Events← 返回个股快讯
WSTEarnings Release财报快讯Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间:
Published: 文章发布:

WST earnings release — EPS beat +20.9% · revenue beat +5.7%West Pharmaceutical Services, Inc. (WST) 财报发布 — EPS 高于预期+20.9% · 营收 高于预期+5.7%

Key Results

Actual vs Consensus

  • EPS: $2.66 vs $2.20 estimate, beat+20.9%.
  • Revenue: $874M vs $827M estimate, beat+5.7%.
  • Profitability and Cash Flow

  • Period: 2026 Q3 period ended 2026-09-30
  • Revenue: $874M; YoY: +8.7%; QoQ: +0.3%
  • Gross profit: $347M; Gross margin: 39.7%
  • Operating income: $267M; Operating margin: 30.6%; YoY: +53.9%; QoQ: +49.3%
  • Net income: $214M; GAAP diluted EPS: $3.02; YoY: +52.9%; QoQ: +39.0%
  • Operating cash flow: $190M; Capex: $39M; Free cash flow: $150M
  • Cash: $464M; Total debt: $305M; Net cash: $159M
  • Official release: West Reports Third-Quarter 2026 Results

    核心结果

    实际值与市场预期

  • EPS:$2.66 vs $2.20 预期,高于预期+20.9%。
  • 营收:$874M vs $827M 预期,高于预期+5.7%。
  • 财务指标

  • 期间:2026 Q3(截至 2026-09-30)
  • 营收:$874M;同比:+8.7%;环比:+0.3%
  • 毛利润:$347M;毛利率:39.7%
  • 经营利润:$267M;经营利润率:30.6%;同比:+53.9%;环比:+49.3%
  • 净利润:$214M;GAAP 稀释 EPS:$3.02;同比:+52.9%;环比:+39.0%
  • 经营现金流:$190M;资本开支:$39M;自由现金流:$150M
  • 现金:$464M;总债务:$305M;净现金:$159M
  • For information only. Not investment advice.内容仅供参考,不构成投资建议。